Our Latest Thinking

We are constantly scanning the health care market for new and interesting developments; then we write about them here. Check out our latest thinking.

FDA

Leavitt Partners Welcomes Mark Hendrickson to the Firm

July 17th, 2019

Salt Lake City, July 17, 2019 –Today, Leavitt Partners welcomes Mark Hendrickson as a Senior Director based in our Washington, D.C. office. Mark comes to Leavitt Partners with more than 20 years of experience in health care policy and government affairs roles in Washington, D.C. advocacy. Mark most recently served as Senior Director of Sciences […]

Read More >

3 Strategies to Help Accountable Care Organizations Boost Savings

June 11th, 2019

Revcycle Intelligence posted “3 Strategies to Help Accountable Care Organizations Boost Savings,” highlighting research from Leavitt Partners and the Duke-Margolis Center regarding ACO case studies.  View the article here.

Read More >

Remarkable Growth of Pharmaceutical Distribution Network to Upsurge the Position of Global Biopharmaceutical Third Party Logistics

June 7th, 2019

Digital Journal posted “Remarkable Growth of Pharmaceutical Distribution Network to Upsurge the Position of Global Biopharmaceutical Third Party Logistics,” highlighting the Pharmaceutical Distribution Security Alliance (PDSA) and its proposed system for Drug Supply Chain Security Act (DSCSA) governance.  View the article here.

Read More >

Political Checkpoint: 2019 National Health Policy Agenda

April 18th, 2019

On April 18, 2019, Leavitt Partners hosted a webinar focused on helping you track the most important health policy developments in Washington D.C.  For details and to listen to the recording, click here.  

Read More >

Leavitt Partners Welcomes Elizabeth Wroe to the Firm

March 26th, 2019

Liz Brings to Leavitt Partners Extensive Federal and State Health Care Policy and Strategy Experience. Salt Lake City, March 26, 2019 –Today, Leavitt Partners is proud to announce and welcome Elizabeth Wroe as a principal based in Washington, D.C. Liz will develop and manage complex, multi-sector alliances, and will advise and inform clients on the […]

Read More >

Pharmaceutical Distribution Security Alliance Releases Proposal for Governance of DSCSA Interoperability

March 25th, 2019

Washington, D.C., March 25, 2018 — The Pharmaceutical Distribution Security Alliance (PDSA), a coalition of more than 25 pharmacies, distributors, logistics operators, manufacturers, and associations, committed to strengthening the nation’s pharmaceutical distribution supply chain through implementation of the Drug Supply Chain Security Act (DSCSA), has released a proposal for Governance of DSCSA Phase II Interoperability. […]

Read More >

FDA’s New Pilot Program Encouraging Innovation

December 6th, 2018

The article discusses the Complex Innovative Trial Designs Pilot Meeting Program, and the opportunity for sponsors with an Investigational New Drug.

Read More >

Implications of the 2018 Midterm Elections

November 16th, 2018

Health care was a central issue in this year’s midterm elections. In the days after the election, many have speculated on what the results mean for U.S. health care policy. Since the Republicans maintained control of the Senate, while the Democrats took control of the House, some see the next two years as a time […]

Read More >